PerPlexity Health Care EU's Stock Coverage
| PILAPILA PHARMA AB | Nov 04, 2026 | HOLD | Reiterated | kr1.50 | 72Ratings | +34.70% | ||
| ONCOZOncoZenge AB | Nov 04, 2026 | SELL | Reiterated | kr3.00 | 48Ratings | +25.98% | ||
| IVACCIntervacc AB | Nov 04, 2026 | HOLD | Reiterated | kr0.73 | 92Ratings | -78.55% | ||
| IRLAB.AIRLAB Therapeutics AB Class A | Nov 04, 2026 | HOLD | Reiterated | kr2.00 | 47Ratings | -5.70% | ||
| FLUIFluicell AB | Nov 04, 2026 | HOLD | Reiterated | kr28.00 | 113Ratings | +33.20% | ||
| EXPRS2ExpreS2ion Biotech Holding AB | Nov 04, 2026 | HOLD | Upgraded | kr0.95 | 97Ratings | +20.95% | ||
| EGTXEgetis Therapeutics AB | Nov 04, 2026 | HOLD | Reiterated | kr10.00 | 55Ratings | -9.90% | ||
| ACTIActive Biotech AB | Nov 04, 2026 | SELL | Reiterated | kr4.00 | 82Ratings | -10.03% | ||
| ACEAscelia Pharma AB | Nov 04, 2026 | SELL | Downgraded | kr0.51 | 51Ratings | -26.23% | ||
| GPIGPI SpA | Nov 04, 2026 | HOLD | Reiterated | €16.00 | 68Ratings | ― | ― |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >PerPlexity Health Care EU activity FAQ
What is the performance of PerPlexity Health Care EU's recommendations?
The percentage of profitable recommendations made by PerPlexity Health Care EU is 47.67%, and the average return per transaction is -1.20%.
What stocks does PerPlexity Health Care EU cover?
PerPlexity Health Care EU mostly covers Paragon Care Limited, Tali Digital, Oryzon Genomics SA stocks.
What was PerPlexity Health Care EU's most profitable rating?
PerPlexity Health Care EU’s most profitable rating was a sell on Neovacs SA stock on Jul 22, 2025. The return on the trade was 99.90%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here